Wang, Ya-Ting http://orcid.org/0000-0002-5057-4083
Zaitsev, Konstantin http://orcid.org/0000-0003-3749-0886
Lu, Qun
Li, Shan
Schaiff, W. Timothy
Kim, Ki-Wook
Droit, Lindsay
Wilen, Craig B. http://orcid.org/0000-0003-2495-9403
Desai, Chandni
Balce, Dale R.
Orchard, Robert C. http://orcid.org/0000-0001-8216-4946
Orvedahl, Anthony
Park, Sunmin
Kreamalmeyer, Darren
Handley, Scott A.
Pfeifer, John D.
Baldridge, Megan T. http://orcid.org/0000-0002-7030-6131
Artyomov, Maxim N.
Stallings, Christina L. http://orcid.org/0000-0002-2747-5618
Virgin, Herbert W. http://orcid.org/0000-0001-8580-7628
Funding for this research was provided by:
Foundation for the National Institutes of Health (K08 A128043, U19 AI42784, R01 AI132697, U19 AI109725)
Pediatric Infectious Diseases Society
Burroughs Wellcome Fund
Crohn’s and Colitis Foundation (326556)
Article History
Received: 23 January 2019
Accepted: 5 November 2019
First Online: 20 January 2020
Change Date: 25 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41564-021-00923-x
Competing interests
: H.W.V. is a founder of Casma Therapeutics and PierianDx. The work reported here was not funded by either company.